Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polyomavirus-associated nephropathy: update on BK virus-specific immunity.

P Comoli1, S Binggeli, F Ginevri

  • 1Transplant Immunology and Pediatric Hematology/Oncology, IRCCS Policlinico San Matteo, Pavia, Italy.

Transplant Infectious Disease : an Official Journal of the Transplantation Society
|June 1, 2006
PubMed
Summary

BK virus (BKV) causes polyomavirus-associated nephropathy (PVAN) in kidney transplant patients. Monitoring BKV-specific immune responses, including antibody titers and T cells, may help predict PVAN risk and disease course.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of canola meal or soybean meal on duodenal flow of nitrogen fractions in dairy cows.

Journal of dairy science·2025
Same author

Evaluation of National Academies of Sciences, Engineering, and Medicine (NASEM, 2021) feed evaluation model on predictions of milk protein yield on Québec commercial dairy farms.

JDS communications·2024
Same author

Current strategies of cell and gene therapy for solid tumors: results of the joint international ESMO and CTIWP-EBMT survey.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

External evaluation of the prediction equation for milk fat yield by the 2021 NASEM dairy model using data from eastern Canadian dairy herds.

JDS communications·2023
Same author

Comparison of feed evaluation models on predictions of milk protein yield on Québec commercial dairy farms.

Journal of dairy science·2022
Same author

Economic and environmental effects of revised metabolizable protein and amino acid recommendations on Canadian dairy farms.

Journal of dairy science·2021

Area of Science:

  • Nephrology
  • Virology
  • Immunology

Background:

  • Polyomavirus-associated nephropathy (PVAN) affects 1-10% of renal transplant recipients, leading to graft loss in over 50% of cases.
  • Risk factors for PVAN are multifactorial, involving recipient, graft, and viral determinants, with a key imbalance between BK virus (BKV) replication and immune control.
  • Intense immunosuppression, HLA mismatches, and donor/recipient serostatus are implicated in PVAN development.

Purpose of the Study:

  • To investigate the role of BKV-specific immune responses in the context of PVAN.
  • To explore the potential of humoral and cellular immunity markers for predicting PVAN risk and disease progression.

Main Methods:

  • Review of existing literature on PVAN pathogenesis and risk factors.
  • Analysis of studies examining BKV-specific antibody titers and T cell responses (CD4+ and CD8+) in renal transplant recipients.

Related Experiment Videos

  • Evaluation of the impact of immunosuppression reduction on PVAN outcomes.

    • Main Results:

    • Reducing immunosuppression in kidney transplant recipients has significantly decreased graft loss due to PVAN.
    • BKV-specific humoral and cellular immune responses are not yet fully characterized but show potential as biomarkers.
    • Changes in antibody titers and BKV-specific CD4+ and CD8+ T cells may correlate with PVAN risk and clinical course.

    Conclusions:

    • The balance between BKV replication and host immune control is critical in PVAN development.
    • Further characterization of BKV-specific immune responses is needed to improve PVAN risk stratification and patient management.
    • Monitoring immune markers could offer a more personalized approach to preventing and treating PVAN in renal transplant recipients.